HoldingsChannel.com
NHS insider buying image
The table below summarizes the most recent NHS insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why NHS insider buys are important for investors to follow.
DateInsiderPriceAmount
6-7-2022
Insider Buy		 Joseph Lind
 $9.20
CAGR » 		$91,952.00
10,000 shares
5-27-2020
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $10.43
CAGR » 		$429,163.87
41,163 shares
5-22-2020
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $10.03
CAGR » 		$173,631.79
17,305 shares
3-17-2020
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $9.08
CAGR » 		$277,931.16
30,593 shares
3-5-2020
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $11.90
CAGR » 		$1,548,735.22
130,112 shares
5-27-2020
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $10.43
CAGR » 		$429,163.87
41,163 shares
5-22-2020
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $10.03
CAGR » 		$173,631.79
17,305 shares
5-20-2020
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $10.05
CAGR » 		$756,428.55
75,286 shares
5-18-2020
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $9.84
CAGR » 		$429,675.08
43,686 shares
5-14-2020
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $9.81
CAGR » 		$789,935.23
80,511 shares
5-12-2020
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $9.95
CAGR » 		$199,431.99
20,038 shares
5-8-2020
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $9.93
CAGR » 		$1,538,818.40
154,980 shares
5-5-2020
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $9.80
CAGR » 		$98,000.00
10,000 shares
5-1-2020
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $9.61
CAGR » 		$201,579.36
20,976 shares
4-28-2020
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $9.37
CAGR » 		$201,200.60
21,476 shares
4-16-2020
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $9.52
CAGR » 		$161,820.96
16,998 shares
4-15-2020
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $9.60
CAGR » 		$412.80
43 shares
4-3-2020
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $8.45
CAGR » 		$582,739.20
68,960 shares
4-1-2020
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $8.56
CAGR » 		$242,785.13
28,357 shares
3-30-2020
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $8.51
CAGR » 		$123,386.49
14,499 shares
3-25-2020
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $7.72
CAGR » 		$5,550.68
719 shares
3-24-2020
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $7.30
CAGR » 		$39,090.72
5,352 shares
3-20-2020
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $8.22
CAGR » 		$847,375.76
103,068 shares
3-13-2020
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $9.58
CAGR » 		$665,183.76
69,430 shares
3-10-2020
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $10.83
CAGR » 		$164,377.74
15,178 shares
3-3-2020
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $11.73
CAGR » 		$1,633,696.49
139,219 shares
4-11-2019
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $11.63
CAGR » 		$1,416,517.24
121,750 shares
4-9-2019
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $11.55
CAGR » 		$1,532,418.18
132,636 shares
4-5-2019
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $11.52
CAGR » 		$1,090,437.95
94,645 shares
3-29-2019
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $11.31
CAGR » 		$206,909.04
18,298 shares
3-27-2019
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $11.28
CAGR » 		$132,783.32
11,769 shares
3-20-2019
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $11.24
CAGR » 		$553,020.69
49,193 shares
3-18-2019
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $11.21
CAGR » 		$86,877.50
7,750 shares
2-21-2019
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $11.09
CAGR » 		$468,626.60
42,245 shares
2-19-2019
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $11.03
CAGR » 		$659,935.93
59,831 shares
2-11-2019
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $10.96
CAGR » 		$224,712.88
20,503 shares
2-8-2019
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $10.92
CAGR » 		$1,063,020.18
97,379 shares
2-5-2019
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $10.79
CAGR » 		$2,079,460.02
192,631 shares
1-29-2019
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $10.51
CAGR » 		$1,221,614.80
116,200 shares
1-25-2019
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $10.44
CAGR » 		$2,142,820.33
205,163 shares
1-23-2019
Insider Buy		 Saba Capital Management, L.P.
>10% Owner		 $10.39
CAGR » 		$2,122,490.28
204,332 shares
1-2-2019
Insider Buy		 Bradley Tank
 $9.60
CAGR » 		$19,196.00
2,000 shares
12-28-2018
Insider Buy		 Bradley Tank
 $9.58
CAGR » 		$372,442.34
38,867 shares
12-27-2018
Insider Buy		 Joseph Lind
 $9.63
CAGR » 		$96,339.00
10,000 shares
11-30-2018
Insider Buy		 Bradley Tank
 $10.27
CAGR » 		$200,570.20
19,532 shares
10-8-2015
Insider Buy		 Thomas P. Oreilly
Portfolio Manager		 $11.99
CAGR » 		$726,793.13
60,622 shares
12-21-2015
Insider Buy		 Bradley Tank
 $9.36
CAGR » 		$262,083.40
28,000 shares
8-25-2015
Insider Buy		 Bradley Tank
 $11.95
CAGR » 		$152,977.77
12,800 shares
7-14-2015
Insider Buy		 Thomas P. Oreilly
 $11.56
CAGR » 		$109,834.15
9,502 shares
9-19-2013
Insider Buy		 Thomas P. Oreilly
 $13.11
CAGR » 		$131,101.00
10,000 shares
7-17-2013
Insider Buy		 Thomas P. Oreilly
 $13.00
CAGR » 		$104,009.60
8,000 shares
6-6-2013
Insider Buy		 Thomas P. Oreilly
 $13.35
CAGR » 		$133,522.00
10,000 shares
5-9-2013
Insider Buy		 Ann H. Benjamin
 $14.35
CAGR » 		$249,676.78
17,395 shares
11-15-2012
Insider Buy		 Thomas P. Oreilly
Portfolio Manager		 $13.01
CAGR » 		$40,600.87
3,120 shares

Also See: Institutional Holders of NHS
Also See: SEC filings

NHS Performance Since Insider Purchase
Below we present the annualized performance delivered by NHS stock since 6-7-2022 (the date of the most recent insider purchase). The performance of the investment from the time NHS insider buying occurred is the ultimate test of whether insiders were right about NHS being a good buy.

Growth of $10,000.00
With Dividends Reinvested
Start date: 06/08/2022
End date: 04/24/2024
Start price/share: $8.92
End price/share: $7.93
Starting shares: 1,121.08
Ending shares: 1,449.22
Dividends reinvested/share: $2.09
Total return: 14.92%
Average Annual Total Return: 7.68%
Starting investment: $10,000.00
Ending investment: $11,492.02
Years: 1.88
 
Growth of $10,000.00
Without Dividends Reinvested
Start date: 06/08/2022
End date: 04/24/2024
Start price/share: $8.92
End price/share: $7.93
Dividends collected/share: $2.09
Total return: 12.37%
Average Annual Total Return: 6.40%
Starting investment: $10,000.00
Ending investment: $11,236.61
Years: 1.88

NHS Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent NHS insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding NHS

NHS — Current Quote
Quotes delayed 20 minutes

Email EnvelopeFree NHS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

NHS — Performance
More Insider Buying
Other companies seeing insider buying close in time to when the NHS Insider Buying occurred are:

BSQR Insider Buying
CBTX Insider Buying
MERC Insider Buying
COST Insider Buying
ATCX Insider Buying
BZFD Insider Buying
NLS Insider Buying
RNXT Insider Buying
WY Insider Buying
NROM Insider Buying

NHS Insider Buying | www.HoldingsChannel.com

Copyright © 2013 - 2024, All Rights Reserved Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.